Icon

QLONILIK (NDA221094)- (0.05MG/ML)

CLONIDINE HYDROCHLORIDE CMP DEV LLC
0.05MG/ML
No Yes
2045-Aug-22 Expired
None None
None No
QLONILIK is a central alpha-2 adrenergic agonist indicated for the treatment of hypertension, to lower blood pressure in adults. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It may be employed alone or concomitantly with other antihypertensive agents.
0 0 0
Total Other Developers None
Drugs with Suitability No
0.05MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.